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Abstract 34 
Background: The department of Haematology and Oncology at the Royal Hospital for Sick 35 
Children (RHSC) in Edinburgh have developed their own nutritional standards specific to paediatric 36 
cancer. We aimed to audit the current nutritional practice in anthropometry, nutritional biochemistry 37 
and malnutrition screening for paediatric cancer patients against nutritional standards to identify 38 
areas for nutritional-practice improvement and progress nutrition-related clinical outcomes.  39 
Methods: A Clinical audit was conducted >20 weeks between 2015 and 2017 in three data 40 
collection locations (inpatient (IP), day-care (DC), or outpatient (OP)) at the RHSC. We included 41 
patients aged 0-18 years and undergoing treatment for diagnosed malignant childhood cancer 42 
(ICCC-3 or Langerhans cell histiocytosis). Data were collected by analysing documentation and 43 
observing clinical practice for frequency and mode of administration of anthropometry, malnutrition 44 
screening, nutritional biochemistry and resulting documentation completion. Results were presented 45 
as descriptive statistics and stratified by percentage of standard met (100%, 99-70%, <70%). 46 
Results: 185 audited patient records (22 IP, 54 DC and 109 OP) were analysed. The areas which 47 
were <70% of the standard were: height and weight documentation for DC; head-circumference for 48 
IP; arm anthropometry assessment for all locations; initial PYMS screening and re-screening in IP; 49 
malnutrition screening in DC and OP; and initial assessment and re-assessment for serum vitamins 50 
D, A, E, B12 and parathyroid hormone levels. 51 
Conclusion: Baseline nutritional practice was successfully established, identifying areas for 52 
practice improvement in the RHSC paediatric Oncology and Haematology Department to be 53 
implemented in the next step of the audit to optimise patients care.  54 
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Introduction  55 
Paediatric cancer remains the most common cause of disease-related childhood mortality in 56 
industrialised societies(1); however, due to advances in diagnosis and treatment, the overall cure 57 
rate has risen to 70-82%, with 76% of patients surviving for 10 years or more(2). The improvement 58 
in survival rates has highlighted the long-term side effects of treatment, particularly in paediatrics 59 
when the child is still growing and developing(3), and emphasising the importance of improving 60 
care to minimise long-term health consequences(4).  61 
Malnutrition, defined as “a state of nutrition in which a deficiency, excess, or imbalance of energy, 62 
protein, and other nutrients causing measurable adverse effects on tissue/body shape, size, 63 
composition and function, and clinical outcome”(5), is multifactorial within paediatric oncology(6). 64 
Sufficient nutritional status at diagnosis and during treatment has been shown to a have significant 65 
positive effect on treatment-response and survivorship(7).  66 
Paediatric oncology patients are at risk of malnutrition due to a range of multifactorial elements 67 
including cancer type, treatment side-effects, and nutritional status at diagnosis(6). For all ICCC-68 
3(8) paediatric cancer patients, roughly 10-20% of patient are under-nourished(7,9,10) and 7-57% 69 
are over-nourished(7) at time of diagnosis. Both forms of malnutrition have been shown to increase 70 
in prevalence during treatment(7,10). Waning nutritional status contributes to impaired immune 71 
function, delayed wound healing, altered drug metabolism and response(11,12), and increases the 72 
risk of morbidity and mortality(6,7,13). Overnutrition may disguise lean mass weight, sarcopenic 73 
obesity, and micronutrient depletion(6); and incorrect lean mass weight may impact drug response 74 
and compound treatment side-effects(14). Long-term side effects of treatment (as seen in survivors 75 
of childhood cancer) include metabolic syndrome, cardiac complications, reduced bone mass 76 
density, secondary cancers(15,16), and premature death in adulthood(3). Nevertheless, some of the 77 
observed health consequences in survivors may be modifiable (i.e. metabolic syndrome)(17) 78 
highlighting a need for nutritional care and monitoring. When patients receive adequate nutritional 79 
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care, clinical outcomes such as treatment response, quality of life and cost of care improve(9). 80 
Appropriate nutritional screening, dietetic assessment and implementation of nutritional care plans 81 
can aid in the timely identification and therapy of nutritionally at-risk patients(6,7,14). 82 
Currently, there are no paediatric oncology-specific nutrition guidelines, nor standardised 83 
nutritional practice(6,7,9,13). And while the scientific literature is relatively consistent with their 84 
nutritional care recommendations, these are not yet expressed in clinical practice(18,19). As a 85 
result, best practice is currently relied upon(6,7,12), highlighting the need to establish evidence-86 
based childhood cancer-specific nutritional guidelines(20). The Oncology and Haematology 87 
department at the Royal Hospital for Sick Children (RHSC) in Edinburgh (Scotland),  is currently 88 
conducting an ongoing quality improvement project (QIP) to develop and implement standardised 89 
nutritional guidelines to maximise their provision of effective and safe nutritional patient care. A 90 
pilot study established local nutritional practice in the Oncology and Haematology Department at 91 
the RHSC(21) and these results were used to develop department-agreed evidence-based nutritional 92 
standards.  93 
The aim of this audit was to identify and assess the current baseline nutritional practice in 94 
anthropometry, nutritional screening and nutritional biochemistry of paediatric oncology and 95 
haematology patients at the RHSC and compare the observed practice to the nutritional 96 
standards(21); thereby aiding in the development of nutritional guidelines and improving clinical 97 
nutritional practice in this patient group.  98 
Methods 99 
The audit was a cross-sectional study conducted in the paediatric Oncology/Haematology 100 
department at the RHSC (NHS South East Scotland service covering  NHS Lothian/NHS 101 




Four researchers (DG, OM, FO, RRI) collected data by analysing patient documentation and by 104 
observing clinical practice pertaining to the nutritional care of all eligible patient records seen in the 105 
inpatient (IP) ward (Ward 2, RHSC Edinburgh), day-care (DC) unit and outpatient (OP) clinic. The 106 
audit was performed over 20 weeks from May 2015-August 2017. 107 
Inclusion criteria were records from children aged >0 to <18 years diagnosed and treated for cancer 108 
(diagnosis via ICCC-3, OR Langerhans Cell Histiocytosis(8)). Exclusion criteria were records of 109 
palliative patients, patients with non-malignant haematological conditions and those diagnosed with 110 
brain tumours (treated with surgery alone). 111 
To establish current nutritional practice, frequency and mode of administration of nutritional 112 
parameters and completion of documentation was gathered in the three settings (IP, DC and OP). 113 
Each patient record was only represented once within each location; patient readmissions were not 114 
added as new patient records. However, a patient record pertaining to one patient could be analysed 115 
separately in each location if the patient was using each clinical service.  116 
The following nutritional parameters were assessed:  117 
(i) anthropometry; weight (kg), height/body length (m)(23), head circumference (cm)(24), 118 
upper arm anthropometry (mid-arm upper circumference (MUAC, cm) and tricep 119 
skinfold thickness (TSF; mm)(25)(26), and plotted growth charts (written and electronic) 120 
with body mass index (BMI; kg/m22) centiles(24)(27);  121 
(ii) malnutritional screening by Paediatric Yorkhill Malnutrition Score (PYMS)(28) and 122 
appropriate referral to and follow-up by the dietitian;  123 
(iii) assessment and management of nutritional bloods for all patients; plasma statuses were 124 
assessed for: vitamin D, vitamin E, vitamin A, vitamin B12, potassium, magnesium, 125 
phosphate, calcium, and albumin. Reference ranges for vitamin D(29) and remaining 126 
nutritional biochemistry(30) assessed by the used by the Royal Infirmary Laboratory of 127 
Glasgow. 128 
These were then compared to RHSC nutritional standards (table 1) (see supplementary material). 129 
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In total, there are 50 different audit criteria discussed in this report (anthropometry: six criteria per 130 
location; malnutrition screening: 11 criteria for IP and one criterion for DC and OP each; nutritional 131 
bloods: 19 criteria in total (locations are grouped together)). Data was obtained from nursing notes, 132 
medical notes, and the online patient data system Trak Care (TrakCare). The researchers observed 133 
the weighing and measuring of patients in each location as able.  134 
All data was recorded on one of three data-collection location specific audit. RHSC nutritional 135 
standards were to be met 100% of the time, except for upper arm anthropometry (50% standard set), 136 
as this was not part of regular clinical practice. 137 
Statistical analysis was conducted using the Statistical Package for the Social Sciences (SPSS) 138 
Statistics Inc. (IMB 2012), Chicago, USA. All continuous variables were tested for normality 139 
(Shapiro-Wilk (n<50) and Kolmogorov-Smirnov (n>50)); all data was normally distributed and 140 
presented as mean (+SD)(31). All remaining statistical analysis was descriptive. Results have been 141 
presented as percentage of RHSC nutritional standard met and colour coded accordingly (100% 142 
met: green; 99-70% met: amber; ≤69% met: red) to aid in highlighting areas requiring the greatest 143 
improvement. Ethical approval for the ongoing QIP was granted from NHS Scotland on the 1st of 144 
June 2007 (NHS REC 06-51104-52). 145 
Table 1 Audit: Summary of Audit Sections Represented in the Audit Tool  
Section Criteria  Assessment Details 
Applicable Data 
Collection Locations  RHSC 
Standard  
IP DC OP 
1 Anthropometry 
Completion and Documentation of Height, 
Weight, and Head Circumference 
   100% 
Completion and Documentation of Mid 
Upper Arm Circumference and Tricep 
Skinfold Thickness 
   50% 
PYMS Completion and Documentation, 
Documentation of Nutritional Status by 
BMI centile 





Paediatric Yorkhill Malnutrition Score 
(PYMS) Completion and Documentation 




Completion of Documented Clinical Notes 
including Anthropometry Documentation 




Completion of Nutritional Review 
Documentation in Dietetic Notes  
   100% 
5 
Nutritional Support at 
Home 
Completion of Documentation of 
Nutritional Support at Home 
   100% 
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6 Physical Activity Advice 
Completion of Verbal and Documented 
Physical Activity Advice 
   100% 
7 Nutritional Bloods 
Documentation and Follow-up of 
Nutritional Bloods 




Documentation of Refeeding Syndrome 
Risk Assessment 
   100% 
9 Supplementation 
Documentation of Vitamin or Mineral 
Supplementation Prescriptions 
   100% 
10 Mealtimes Observation of Ward Meal-Time Practices    100% 
11 
Nutritional Advice for 
Neutropenic Patients 
Completion of Documentation of 
Nutritional Advice for Neutropenia given 
to Neutropenic Patients 
   100% 
12 
Nutritional Support on 
the Ward 
Completion of Documentation of 
Nutritional Support on the Ward 
   100% 
13 
Food and Fluid Record 
Charts 
Completion of Food and Fluid Record 
Chart Documentation 
   100% 
14 RD Referral Process 
Completion of Verbal and Documented 
RD Referrals and RD follow-up  
   100% 
Table 1 presents the RHSC nutritional standards 146 
*Full nutritional bloods only recorded for “on treatment” patients. Any patient in survivorship or late effects will only be audited on 147 
vitamin D testing. Abbreviations: registered Dietitian, RD; Royal Hospital for Sick Children in Edinburgh, Scotland, RHSC. 148 
This report only covers sections 1, 2, 3, 7, and 14 of the wider audit and QIP 149 
Results  150 
 151 
Population Demographics: The Audited Patient Records 152 
Over half of patient records stemmed from OP and were on treatment at time of the audit (62%, 153 
n=114). The researchers recorded all documented RD input from all patient records (current care for 154 
IP and DC, and current and past care for OP) and found that 57% (n=84) of all audited patient 155 
records had documented RD input.  156 
Table 2 Population Demographics 
  Data Collection Location  
  n (%) 
 Inpatient Day-Care Outpatient  Total 
 22 (12) 54 (29) 109 (59)  185 (100) 
On treatment  22 (100) 54 (100) 38 (35)  114 (62) 
Survivorship (<5years)  - - 61 (56)  61 (33) 
Late effects (>5years)  - - 10 (9)  10 (5) 
Documented RD input  10 (46) 13 (76)* 61 (56)  84 (57)° 
Table 2 presents the location of data collection, patient stage of treatment, and documented RD input. 157 
*37 DC records had missing data on RD input and were excluded from the percentage of documented RD input (n=17); °therefore 158 





Table 3 Anthropometry Results by Data Collection Location 
  Location of Data Collection 










yes no other n/a 
   
n n (%) n (%) n (%) n (%) 
 Total •  
Weight 22 20 (91) 0 (0) 2 (9) - 
 22 (100)  100% 
Height 22 15 (68) 4 (18) 3 (10) - 
 18 (81)  100% 
HC 22 0 (0) 4 (10) - 18 (90) 
 0 (0)  100% 
MUAC 22 0 (0) 22 (100) - 0 (0)  0 (0)  50% 
TSF 22 0 (0) 22 (100) - 0 (0)  0 (0)  50% 
          
 
 Location of Data Collection 










yes no other n/a 
   
n n (%) n (%) n (%) n (%) 
 Total •  
Weight 54 28 (52) 25 (46) - 1 (2)  28 (52)  
100% 
Height 54 11 (20) 42 (78) - 1 (2)  11 (20)  
100% 
HC 54 0 (0) 0 (0) - 54 (100)  -  
100% 
MUAC 54 0 (0) 54 (100) - 0 (0)  0 (0)  
50% 




      
 
 Location of Data Collection 










yes no other n/a 
   
n n (%) n (%) n (%) n (%) 
 Total •  
Weight 109 96 (88) 1 (1) 12 (11) -  108 (99)  
100% 
Height 109 94 (86) 3 (3) 12 (11) -  106 (97)  
100% 
HC 109 1 (1) 0 (0) - 108 (99)  1 (100)  
100% 








Table 3 presents the Anthropometry results by data collection location. 162 
•Total n is all "yes" and "other" answers; Total % = (Total n / all "no")*100; "n/a" answers have been excluded from the total n and 163 
total %; "n/a" answers have been excluded from the total n and total %. 164 
Abbreviations: HC, head circumference; MUAC, mid-upper arm circumference; TSF, tricep skinfold thickness; n/a, not applicable; 165 
RHSC, Royal Hospital for Sick Children Edinburgh. 166 
 167 
Weights and heights were measured on Mondays and Thursdays in inpatients, where patient weight 168 
and height was measured and documented in accordance with standards for 81% (n=18) of records. 169 
9 
 
Where staff were unable to take both weight and height (n=3) appropriate reasons were 170 
documented, and height was taken at the next suitable time.  171 
For DC patients (n=54), only 11 patient records had a correctly documented height and weight. 172 
Documentation showed that patients could go months without height being documented; for one 173 
patient an updated height had not been recorded for seven months. At the time of the audit all 174 
recorded DC anthropometry was documented on weight and height lists; only two of the 43 records 175 
without height or weight had documented reasons for lack of recording. There were no TrakCare 176 
anthropometry entries made by DC although a computer was available in the DC assessment room. 177 
If patients did have TrakCare anthropometry entries it was due to them being documented in either 178 
IP or OP.  179 
OP weight and height was recorded for 99% (n=108) and 97% (n=106) of patients respectively and 180 
almost meeting the 100% standard. When staff were unable to document weight or height (“other”), 181 
appropriate reasons were documented. All recorded OP anthropometry was documented directly 182 
onto TrakCare records. 183 
HC is to be measured in centimetres for all patients ≤2 years of age; this only applied to five patient 184 
records (IP=4 and OP=1); IP measurements were not recorded; however, outpatient met the RHSC 185 
standard. No reasons were documented for the missing IP HC measurements.  186 
TSF and MUAC measurements are currently not part of regular nutritional care in the Oncology 187 




Figure 1: Bar-chart of the Anthropometry Results (all data collection locations combined) vs. expected RHSC Anthropometry 190 
Standards. Weight measurements were taken in 85% of patients (n=158), height measurements were taken in 74% of patients 191 
(n=136), and HC was recorded for 20% (n=1) of the applicable patients. Abbreviations: HC, head circumference; MUAC, mid-upper 192 
arm circumference; TSF, tricep skinfold thickness; RHSC, Royal Hospital for Sick Children Edinburgh. 193 
 194 
Table 4 Nutritional Status according to Body Mass Index Results 
 Data collection Location  
n (%) 
Nutritional Status classified by BMI 
centile•  
Inpatient Day-Care Outpatient  Total 
9 (100)* 17 (100) 105 (100)  131 (100)* 





























Well-nourished 5 (56) 6 (35) 53 (58)  64 (49) 
Over-nourished 0 (0) 3 (18) 20 (18)  23 (17) 
Obese 0 (0) 0 (0) 21 (18)  21 (16) 
       
Unknown  
(due to lack of documentation) 
4 (44) 8 (47) 6 (2)  18 (14) 
       
RHSC Nutritional Status Completion Standard for 100% Completion (n=131 (100%)) including all under-nourished, well-nourished, over-
nourished, and obese; with 0% Unknown (n=0 (0%)). 
       
Table 4 presents the nutritional status of all audited patient records according to BMI centile across all data collection locations. 54 195 
patient records were excluded due to missing data, they were not included in calculating the percentage standard met (IP=13, DC=37, 196 











































•BMI centile definitions: undernourished: <2nd centile, well-nourished: 2nd- 91st centile, over-nourished: >91st - 98Th centile, obese: 198 
>98th centile;*one patient record was not-applicable due to BMI centiles being not age appropriate for the patient (<2years); ° Total 199 
% (total number of patients with a nutritional status) to be compared to RHSC Standard (100%). 200 
Abbreviations: HC, head circumference; BMI, Body Mass Index; RHSC, Royal Hospital for Sick Children Edinburgh 201 
 202 
In regard to RD input in relation to BMI centile nutritional status, 100% of patients documented as 203 
underweight had RD input (n=5), 19% of well-nourished patients (n=12) had documented input, 204 
26% of over-nourished (n=6) and 14% of obese patients (n=3) had documented RD input. 205 
 206 
Paediatric Yorkhill Malnutrition Score (PYMS) and the RD Referral Process 207 
Table 5 PYMS Results and RD referral 
 Location of Data Collection   RHSC 
Standard  n (%)  
       
  Inpatient  Day-Care  Outpatient  
 19 (100)*  54 (100)  109 (100)  (%) 
PYMS in Place• yes  no  no  yes 
PYMS screened 16 (84)  0 (0)  0 (0)  100 
PYMS completed  
(of those screened) 
16 (100)  0 (0)  0 (0)  100 
        
Average PYMS score (μ (±SD))° 1.7 (1.1)°  -  -  - 
PYMS of 0 2 (11)  -  -  - 
PYMS of 1 6 (32)  -  -  - 
PYMS of 2 4 (21)  -  -  - 
PYMS of 3+ 4 (21)  -  -  - 
PYMS score unknown* 3 (15)  -  -  - 
        
Following data for total number of PYMS screened patients (n=16) 
        
Weight recorded on PYMS 16 (100)  -  -  100 
Height recorded on PYMS 15 (94)  -  -  100 
        
If PYMS 0, appropriate re-screening 1 (50)  -  -  100 
If PYMS 1, appropriate re-screening 4 (67)  -  -  100 
If PYMS 2+, appropriate re-screening 4 (50)  -  -  100 
        
PYMS Referral to RD (n=8 (100%)) 
        
If PYMS 2+, RD referral (within 24 hr) 8 (100)  -  -  100 
Patient seen by RD (within 72 hr) 6 (75)  -  -  100 
If PYMS 3+, regular RD review 3 (75)  -  -  100 
Table 5 presents the PYMS documentation and execution results by data collection location; none of the data collection locations 208 
fully met the PYMS standards. 209 
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*IP records (n=3) were excluded from the total because they were non-applicable (height was unavailable with a documented reason; 210 
therefore, the document was excluded; two other individuals were too unwell to be assessed). °PYMS Score results are normally 211 
distributed (n<50; Shapiro-Wilk test for normality, p=0.161). • PYMS was not available on Day-Care or in Outpatients. Therefore, it 212 
was not possible to audit its completion. Abbreviations: RD, registered dietitian; PYMS, Paediatric Yorkhill Malnutrition Score; µ, 213 
mean; SD, Standard deviation; RHSC, Royal Hospital for Sick Children Edinburgh 214 
 215 
None of the data collection locations fully met the PYMS standards. The lowest IP standard 216 
compliance was in relation to appropriately re-screening a patient. In DC and OP, patients were not 217 
screened for malnutrition using PYMS and no alternative malnutrition screening tool was used in its 218 
place. When asked, staff explained that clinical judgement was used to refer to the RD. Of the 18 219 
patient records who had an unknown nutritional status (table 4), only 11 were screened using 220 
PYMS, resulting in 7 patients with no manner of anthropometric assessment or malnutrition 221 
screening (data not shown). The IP ward staff met initial screening standards except for three 222 
PYMS re-screening criteria; one patient with a PYMS score of 2+ was not re-screened with no 223 
documented reason at the time of the audit. The other two audit criteria which did not meet the 224 
100% standard involved RD care; one patient was not seen within 72 hours of a referral and one 225 
patient did not receive appropriate RD follow-up (there were no reasons documented for either of 226 
the criteria). 227 
 228 
Nutritional Biochemistry 229 
Table 6 The Assessment and Reassessment of Nutritional Bloods from audited patient 





Assessed  Appropriately Reassessed  
  Yes No Total Yes No n/a Total • 
n % n (%)           n (%) n (%) n (%)          n (%)          n (%) n (%) 
Vitamin D 182 100 33 (18) 149 (82) 33 (18) 2 (6) 31 (94) 0 (0) 2 (6) 
Vitamin A 185 100 11 (6) 174 (94) 11 (6) 1 (9) 10 (91) 0 (0) 1 (9) 
Vitamin E 112 100 11 (10) 101 (90) 11 (10) 2 (18) 8 (73) 1 (9) 2 (20) 
Vitamin B12 112 100 26 (23) 86 (77) 26 (23) 3 (11) 22 (85) 1 (4) 3 (12) 
Potassium 112 100 112 (100) 0 (0) 112 (100) 104 (93) 7 (0) 1 (4) 104 (94) 
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Magnesium 112 100 110 (98) 2 (2) 110 (98) 101 (96) 5 (2) 1 (2) 101 (93) 
Phosphate 112 100 111 (99) 1 (1) 111 (99) 100 (90) 11 (10) 0 (0) 100 (90) 
Calcium 112 100 112 (100) 0 (0) 112 (100) 103 (92) 9  (8) 0 (0) 103 (92) 
PTH 106 100 9 (8) 97 (92) 9 (8) 0 (0) 9 (100) 0 (0) 0 (0) 
Albumin 112 100 112 (100) 0 (0) 112 (100) - - - - 
Table 6 presents the assessment and reassessment results of all nutritional bloods (except vitamin D) from all “on treatment” audited 230 
patient records and vitamin D assessment and reassessment results for all patient records regardless of treatment stage. 231 
• N/A removed from total; total taken from those who were assessed to the nutritional blood in question. 232 
Abbreviations: N/A, not applicable; RHSC, Royal Hospital for Sick Children Edinburgh 233 
 234 
Vitamin D, A, E, B12, and PTH assessment did not meet the RHSC nutritional standard; and none of 235 
the nutritional bloods were reassessed according to the standards. Vitamin D status (29) of all 236 
assessed patients (n=33) were documented; 27% (n=9) of patients had optimal vitamin D levels 237 
(>75 µmol/L), 24.5% (n=8) had sub-optimal levels (50-75 µmol/L), 24.5% (n=8) had insufficient 238 
levels (25-50 µmol/L), and 15% (n=5) were vitamin D deficient (<25 µmol/L). Three patients (9%) 239 
had unknown levels as lab results were never obtained. 94%  (n=31) of the patients had no follow-240 
up regardless of vitamin D status or failed results; however, current laboratory practice requires 241 
clinicians to wait 340 days for a re-request (30). There was no way for healthcare professionals to 242 
attach a note to the biochemistry results on TrakCare as to why an assessment was not carried out.  243 
In total, 50 criteria were audited across all data collection locations; 18% met the 100% RHSC 244 
nutritional standard, 28% were between 99-70% of the RHSC nutritional standard and 52% were 245 
69% or below the RHSC nutritional standard. The areas which were 69% or below were height and 246 
weight for DC, HC for IP, MUAC and TSF for all locations, BMI documentation for IP and DC, 247 
PYMS screening for DC and OP, PYMS rescreening for IP and Vitamin D, E, A, B12 and PTH 248 
assessment (and reassessment) for all appropriate patients.  249 
Discussion 250 
The audit successfully established current nutritional practice in Oncology and Haematology 251 
department; identifying areas of both good and sub-optimal practice and setting a baseline for the 252 
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next stage of the audit. Good practices included PYMS screening in IP, height and weight 253 
documentation in OP, and potassium, magnesium, phosphate, calcium and albumin assessment and 254 
re-assessment. Areas for improvement included anthropometric assessment in DC, malnutrition 255 
screening in DC and OP, and the incorporation of arm anthropometry and Vitamins E, A, B12, D 256 
and PTH nutritional bloods as a part of routine practice. These results are not surprising considering 257 
the lack of national or world-wide agreed nutritional standards and variable nutritional practice 258 
within paediatric oncology(32). While there has been a long interest in improving oncological 259 
outcomes, focusing on the nutritional status of patients to improve health outcomes has become a 260 
more recent focus, with an interest in establishing basic standards of nutritional 261 
assessment(7,20,32,33). In lieu of no nutritional standards, a minimum of recommended British 262 
Dietetic Association nutritional practice should be met in the UK(14). Currently, there are no other 263 
published projects assessing the implementation of paediatric oncology specific nutritional 264 
standards in the UK. 265 
Anthropometry 266 
Linear growth and weight assessment are critical in nutritional care(24); regular and accurate 267 
measurements are used to assess and monitor nutritional status(7,34), and body weight are required 268 
for chemotherapy/treatment dose calculations(14). With regular measurements, height, weight and 269 
height for weight z-scores can be tracked and discrepancies can be highlighted, examined and 270 
action taken(24,27,35). Patients who are at risk of poor linear growth(36) or at risk of protein energy 271 
malnutrition(12) may go unrecognised if unmonitored. This is particularly important in paediatric 272 
oncology because different tumour types have different effects on the child’s body composition, 273 
fluid shifts and development(6). Regular anthropometric assessment throughout treatment allows 274 
clinicians to monitor development and changes(6). Patients diagnosed with aAcute Lymphoblastic 275 
Leukaemia (ALL) have been observed to have a slower height growth during treatment, whereas 276 
the height growth of patients with solid tumour diagnosis do not seem to be affected(36). This is 277 
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mirrored in survivorship and late effects where body composition varies between the different 278 
diagnosis’ and treatments, and monitoring anthropometry is critical for catch-up growth(7). While 279 
height and weight anthropometry documentation were achieved in IP and OP, DC documentation 280 
(TRAK or patient records) left the majority of patients without appropriate anthropometric 281 
monitoring. Furthermore, patient records without a calculated BMI and no other means of 282 
anthropometric assessment provided limited means of tracking growth or weight stability 283 
throughout treatment. Head circumference (cm) for age is used to assess growth in children aged <2 284 
years and used to detect severe PEM, faltering growth or extreme chronic malnutrition in the first 285 
few months after birth(37). Only one of the five applicable patients were measured (IP); however, 286 
there is no documentation prompt for HC, increasing the chances of incompletion.  287 
Arm anthropometry is not currently part of RHSC regular clinical practice. There is strong scientific 288 
evidence that arm anthropometry should be included in regular anthropometric assessment, as BMI 289 
and weight for height can be affected by oedema and tumour weight, disguising changes in body 290 
composition(6,20,38). Arm anthropometry is also recommended as a part of appropriate dietetic 291 
practice in paediatric oncology(14,39,40) and a means of assessing those where weight and height 292 
are unavailable(41). MUAC and TSF measurements in relation to population reference ranges(24) 293 
have been shown to be more consistent at measuring undernutrition and overnutrition prevalence in 294 
relation to body composition than BMI in paediatric cancer patients at diagnosis, throughout 295 
treatment and into survivorship(6,40,42). Where the gold standard dual-energy X-ray 296 
absorptiometry (DEXA) assessment is unavailable, MUAC and TSF are an effective and cheaper 297 
evaluation of body composition changes and the detection of sarcopenic obesity(6,7,14,18,43,44); 298 
which are currently undetectable with BMI and height for weight alone. Arm anthropometry is 299 
currently recommended as a nutritional assessment method for paediatric oncology patients world-300 
wide(18,39,40,44–46); particularly when resources are limited. However, more research in 301 
establishing updated reference ranges(47–49) is critical to accurate assessment and monitoring. 302 
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Nutritional Screening  303 
Quality Improvement Scotland state that all patients should be screened for malnutrition risk with a 304 
validated tool appropriate to the patient population in accordance with NICE guidelines(50,51) on 305 
admission and re-screened weekly for maximal effectiveness. Nutritional screening tools are 306 
designed to alert non-dietetically trained clinical staff of malnutrition risk and provide a clear path 307 
for referral to dietetic services(52). IP currently use PYMS(28); a validated tool (which uses the 308 
patients’ BMI, recent weight loss, current nutrient intake and risk of future reduced nutrition intake 309 
to calculate the patients’ nutritional risk) to detect energy/protein undernutrition in inpatients aged 310 
1-18 years. Designed for inpatients, PYMS is suitable for this specific population, and in lieu of an 311 
alternative tool, should be used in all locations. The inclusion of anthropometric measures of body 312 
composition (i.e. MUAC and TSF) or estimation of nutritional risk by diagnosis, cancer type and 313 
treatment intensity (ITR-3)(14) into nutritional screening could result in a more thorough and 314 
accurate screening(21,53–55). The un-met 72 hr RD follow-up standard may be indicative of 315 
incomplete documentation or that dietetic department requires more staff to meet these standards of 316 
practice; however, this is speculation and requires further investigation to be conclusive. Both DC 317 
and OP do not complete PYMS as a part of regular clinical practice. Instead, if a patient is seen in 318 
DC or OP alone, and is not currently known to the dietetic service, clinical staff will refer the 319 
patient on to the RD if they feel input is required. However, this risks a patient going 320 
unrecognised(14) and potentially compromising early malnutrition detection, particularly if they do 321 
not have updated anthropometry and no means of tracking changes. A means of improving practice 322 
could be to include a digitised PYMS (or a population specific(54)) tool on TRAK, such as in the 323 
adult services. This would allow for all TRAK authorised users to follow their patient’s nutritional 324 
care more closely, and for the system to flag changes in nutritional status as they appear. 325 
Nutritional Blood Test Monitoring 326 
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The audit indicated that current assessment of select plasma and serum parameters are more closely 327 
associated with monitoring electrolytes and traditional markers (i.e. albumin) than to assess 328 
nutritional abnormalities. Contrary to current vitamin D public health(56) and population 329 
specific(57) concerns, serum/plasma vitamin D assessment is not part of routine practice. Of the 330 
patients who were measured and received results, vitamin D status varied, with just under half being 331 
either insufficient or deficient with no follow-up assessment. This distribution echoes the results 332 
found by a systematic review investigating the same clinical population, where 14% of the 333 
population was deficient and 23% insufficient(57,58). However, the review highlighted the current 334 
lack of evidence for specific cancer/treatment type and stage. There is a demand for further vitamin 335 
D assessment in this patient group to fully establish the prevalence of vitamin D insufficiency and 336 
deficiency, to minimise the known long-term consequences of rickets, increased risk of bone 337 
fractures and osteomalacia later in life(29,56). PTH, calcium and phosphate status are all 338 
confounding factors for bone turnover when assessing vitamin D status and should be assessed 339 
alongside Vitamin D status(29). While calcium and phosphate assessment were above 90% of the 340 
standard, PTH assessment was not, potentially further obstructing the available vitamin D results. 341 
Vitamins A, E, and B12 did not meet RHSC nutritional standards; however, their assessment is not 342 
currently part of routine practice. This is particularly perilous for vitamin A, as it appears to be the 343 
most abnormal assessed-nutritional-blood. While there is limited research on plasma micronutrient 344 
concentrations and clinical paediatric oncology outcomes, there is a call for an increase in 345 
monitoring of nutritional bloods after finding that low vitamin A and antioxidant intake in patients 346 
with ALL was associated with adverse chemotherapy side effects(59). Particularly when 347 
considering that observed paediatric cancer patients’ anti-oxidant (vitamins A, E, C, etc.) intakes 348 
are low(60) and oxidative stress is high(61). In addition, several studies have indicated that plasma 349 
levels of vitamins A, E and B12 are lower in children with cancer and undergoing treatment than in 350 
healthy controls(62,63), and micronutrient insufficiencies may potentially be cancer specific(61). 351 
Most plasma micronutrient levels appear to be sub-optimal for this patient group(59), however, 352 
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patients may also be at risk of excessive plasma concentrations during treatment due to a suspected 353 
clearing impairment(7). 354 
Abnormal nutritional plasma concentrations in paediatric oncology patients could compound 355 
existing complications; exacerbating cancer and treatment side-effects, such as reduced peak bone 356 
mass in patients with undetected Vitamin D(57,64) or oxidation damage in patients with anti-357 
oxidant (vitamins A, and E) deficiencies(61,65). Patients suffering from side-effects which affect 358 
dietary intake may have greater difficulties in replenishing micronutrient deficiencies or 359 
inadequacies(7). Additionally, micronutrient deficiency/excess can be masked by a patient’s 360 
phenotypic nutritional status, placing both normally-nourished and over-nourished patients at risk of 361 
micronutrient malnutrition if micronutrient assessment is not a part of routine practice(9). Since 362 
micronutrient concentrations are rarely assessed within paediatric oncological research, the 363 
prevalence of plasma micronutrient levels at diagnosis and throughout treatment are relatively 364 
unknown. This could be due to non-standardised assessment, lack of nutrient specific research 365 
and/or a scarcity of incorporating regular nutritional blood assessment into clinical practice. 366 
Whether abnormal plasma micronutrient concentrations are due to cancer aetiology or other factors, 367 
it highlights a nutritional risk and a need for intervention in this population. Routine assessment and 368 
monitoring of nutritional blood tests is an important aspect of providing a complete nutritional 369 
assessment to paediatric cancer patients(7,61).  370 
Improving Practice 371 
The first thing to consider is that this is the first stage of an audit. It is neither unexpected for the 372 
standards to have not met the 100% compliance target, nor are these results indicative of “poor” 373 
nutritional care; this is the first time such an audit has been carried out on this ward. The staff and 374 
department’s desire to both assess and improve their clinical practice is exemplary. The next stage 375 
of the audit is to implement changes so that the standards are met in the future(22). Changes should 376 
not increase current work load yet should minimise complications, maximise efficacy, and take 377 
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current routine into consideration; such measures will help ensure their long-term sustainability(66). 378 
Changes should be implemented systematically with planned checks and support along the way; it 379 
may be advisable to use a guide or model designed specifically for NHS institutions(67). While 380 
conducting the audit, communication difficulties were observed between different specialties (i.e. 381 
doctors, nurses, HCPs) and between different locations (i.e. IP vs. OP); these and further barriers 382 
need to be identified and amended so that the suggested changes can be effectively 383 
implemented(68). A critical factor dictating the success of an audit is the leader(ship)s’ ability to 384 
adapt solutions and strategies to implement the improvements(22). The clinical staff who will be 385 
implementing the changes need to have the power to act and receive the appropriate support from 386 
all applicable disciplines; to ensure that this is possible further clinical training may be 387 
required(66,68). 388 
The main staff-perceived barrier to meeting the standards was time and staffing. Open discussion 389 
amongst team leads is required to establish why certain standards (i.e. anthropometry in DC) were 390 
not met. Three general recommendations are made to improve the clinical practice highlighted 391 
through this audit: development of more nutrition standard friendly documentation, incorporation of 392 
digitised versions of all amended documentation onto TrakCare and improvement in documentation 393 
compliance of all RHSC nutritional standards (Table 7). It is of utmost importance that the 394 
identified issues are addressed, and improvements are incorporated/implemented into clinical 395 
practice to the highest possible standard. To aide in this endeavour, the locations where practice met 396 
the standards could be observed to find a solution for other locations (i.e. anthropometry in OP). 397 
Several standards could improve when the transition to digital documentation is complete and all 398 
anthropometry is entered onto TrakCare, as seen in OP where all measurements were recorded. 399 
There were mixed feelings of willingness to incorporate arm anthropometry into routine practice. 400 
Those who did express enthusiasm felt that they would benefit from further training and those who 401 
were more uncertain felt as if they were not qualified to conduct these measurements. These areas 402 
would need to be addressed when implementing changes. One way of improving documentation 403 
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could be to include a digitised version of the PYMS tool on TRAK, such as in the adult services 404 
with the digitised version of MUST (BAPEN’s Malnutrition Universal Screening Tool)). This 405 
would allow for all TRAK authorised users to follow their patient’s nutritional care more closely, 406 
and any anthropometry entries to automatically calculate the patient’s malnutrition score; raising 407 
dietetic awareness sooner and reducing staff workload. Finally, the lack of achieved anthropometry 408 
standards could be as a result of a lack of understanding of the importance and sensitivity of these 409 
measurements in this vulnerable patient population; this could be rectified by additional training. 410 
However, this would need to take current staff workload into consideration. If standards are not 411 
met, current patient care can become compromised, potentially affecting short- and long-term 412 
outcomes. In addition, a medical institution which does not meet their standards, reduces their focus 413 
on furthering clinical care and evidence based practice; thereby compromising future patient 414 
care(69). 415 
Table 7 Suggested Clinical Changes to Meet RHSC Nutritional Standards 
     
Audit Criteria not 
meeting RHSC 
Nutritional Standard 
Location Suggested Clinical Change 




Lead staff member responsible for implementing changes and ensuring appropriate training (or re-training) is received: 
ward consultant on QIP. 





Ensure all appropriate patients have 
their height and weight measured and 
documented; enter all measurements 
onto TrakCare. 
Nursing Staff  
DC/IP 
As long as not entered on TrakCare: 
Introduce appropriate growth charts to 
document, pot and track patient's height 
and weight. 
Department/ 






Ensure all appropriate patients have 
their HC measured and documented; 
enter all measurements onto TrakCare. 
All Department Staff ? 
ALL 
Amend documentation (include on 
malnutrition tool) to avoid in-complete 
assessment. 
Department Leads * 
Arm Anthropometry  
(Section 1) 
ALL 
Incorporate arm anthropometry into 
routine practice. 
Nursing Staff and RD  
ALL 
Amend documentation (include on 
malnutrition tool/anthropometry charts) 
to avoid in-complete assessment. 
Department Leads 




Amend TrakCare Anthropometry Chart 
to include Arm Anthropometry fields 
(MUAC and TSF). 
Department Leads 






Incorporate PYMS into routine 
practice. 
Nursing Staff ? 
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Table 7 presents the suggested clinical changes based on the audit shortcomings so that RHSC nutritional standards are met in the 416 
future. Training Required Answer Key: , training required; , no training required; ?, potential re-training required; *, training 417 
required if proposed change is implemented. Abbreviations: IP, Inpatient, DC; Day-care; OP, Outpatient; RHSC, Royal Hospital for 418 
Sick Children in Edinburgh; Registered Dietitian, RD; IT, Information Technology 419 
 420 
Limitations 421 
Study limitations included that the hospital was converting from paper to digital record keeping, 422 
and that the RHSC is relocating to a new location; added confusion to clinical practice and the 423 
auditing process. In addition, there were staff shortages and the ward staff suffered an unexpected 424 
loss during the 2017 audit, placing an even greater demand on an already strained workload. 425 
Conclusion 426 
The audit successfully compared current paediatric RHSC oncology nutritional practice to internal 427 
RHSC nutritional standards and established baseline practice. 82% of the 50 audit criteria did not 428 
meet the 100% standard, highlighting areas for improvement and the next step in the audit cycle. 429 
The audit areas requiring improvement were appropriate height and weight assessment and 430 
documentation in DC; head-circumference measurements in IP; incorporating arm anthropometry 431 
assessment into routine clinical dietetic practice; introduction of malnutrition screening in DC and 432 
OP; and routine nutritional biochemistry assessment throughout the department. Appropriate 433 
recommendations will be made so that RHSC nutritional standards are met in the future. If 434 
ALL 








Incorporate assessment of Vitamins D, 















Develop Checklist to ensure all 







Ensure full documentation of all 
nutritional standards until 
documentations amendments made. 
All relevant 
authorities and 
affected staff  
? 
ALL 
All clinical staff involved in patient 
assessment should have access to 
TrakCare and ensure all documentation 







successfully executed, these changes could progress clinical nutritional practice and thereby 435 
improve short and long term clinical and nutritional outcomes in paediatric Oncology and malignant 436 
Haematology patients. 437 
  438 
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